Table 2.
Treatment protocols and ovarian response for 112 IVF cycles among 84 women
| Cycles (n = 112) | |
|---|---|
| IVF protocol [n(%)] | |
| Luteal phase | 74 (66) |
| LDLL | 66 (59) |
| RDLL | 7 (6) |
| HDLL | 1 (1) |
| Flare | 26 (23) |
| Antagonist | 12 (11) |
| hCG trigger dose [n(%)] | |
| ≤5000 IU | 24 (21) |
| 10 000 IU | 88 (79) |
| Peak oestradiol (pg/ml) | |
| Mean ± SD | 2004 ± 838 |
| Range | 551–4455 |
| Total oocytes retrieved per cycle (n) | |
| Mean ± SD | 10.4 ± 5.3 |
| Range | 1–27 |
Eighteen women contributed two IVF cycles, five women contributed three IVF cycles.
IVF, in vitro fertilization; LDLL, low-dose leuprolide lupron; RDLL, regular-dose leuprolide lupron; HDLL, high-dose leuprolide lupron; hCG, human chorionic gonadotropin.